Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides

NCT02159937 is registered in ClinicalTrials.gov with Recepta Biopharma as lead sponsor.

NCT NCT02159937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02159937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides
Lead sponsor
Recepta Biopharma
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
December 31, 2014
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer